{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T19:32:51Z","timestamp":1782156771121,"version":"3.54.5"},"reference-count":25,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":820,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1002\/jcph.112","type":"journal-article","created":{"date-parts":[[2013,6,3]],"date-time":"2013-06-03T13:10:18Z","timestamp":1370265018000},"page":"812-818","source":"Crossref","is-referenced-by-count":25,"title":["Cancer Cachexia Raises the Plasma Concentration of Oxymorphone Through the Reduction of CYP3A But Not CYP2D6 in Oxycodone-Treated Patients"],"prefix":"10.1002","volume":"53","author":[{"given":"Takafumi","family":"Naito","sequence":"first","affiliation":[{"name":"From the Department of Hospital Pharmacy; Hamamatsu University School of Medicine; Hamamatsu; Shizuoka; Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Tashiro","sequence":"additional","affiliation":[{"name":"From the Department of Hospital Pharmacy; Hamamatsu University School of Medicine; Hamamatsu; Shizuoka; Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ishida","sequence":"additional","affiliation":[{"name":"From the Department of Hospital Pharmacy; Hamamatsu University School of Medicine; Hamamatsu; Shizuoka; Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Oncology Center; Hamamatsu University School of Medicine; Hamamatsu; Shizuoka; Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"From the Department of Hospital Pharmacy; Hamamatsu University School of Medicine; Hamamatsu; Shizuoka; Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,3]]},"reference":[{"key":"10.1002\/jcph.112-BIB0001|jcph112-cit-0001","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/dmd.32.4.447","article-title":"Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes","volume":"32","author":"Lalovic","year":"2004","journal-title":"Drug Metab Dispos."},{"key":"10.1002\/jcph.112-BIB0002|jcph112-cit-0002","first-page":"101","article-title":"Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine","volume":"207","author":"Beaver","year":"1978","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1002\/jcph.112-BIB0003|jcph112-cit-0003","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/ALN.0b013e31819faa54","article-title":"Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone","volume":"110","author":"Nieminen","year":"2009","journal-title":"Anesthesiology."},{"key":"10.1002\/jcph.112-BIB0004|jcph112-cit-0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00228-008-0568-5","article-title":"Voriconazole drastically increases exposure to oral oxycodone","volume":"65","author":"Hagelberg","year":"2009","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1002\/jcph.112-BIB0005|jcph112-cit-0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00228-011-1093-5","article-title":"Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study","volume":"68","author":"Andreassen","year":"2012","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1002\/jcph.112-BIB0006|jcph112-cit-0006","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.1332","article-title":"Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients","volume":"93","author":"Bosaeus","year":"2001","journal-title":"Int J Cancer."},{"key":"10.1002\/jcph.112-BIB0007|jcph112-cit-0007","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1152\/physiol.00019.2005","article-title":"Molecular pathways leading to cancer cachexia","volume":"20","author":"Tisdale","year":"2005","journal-title":"Physiology."},{"key":"10.1002\/jcph.112-BIB0008|jcph112-cit-0008","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/bbrc.2000.3219","article-title":"Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes","volume":"274","author":"Pascussi","year":"2000","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1002\/jcph.112-BIB0009|jcph112-cit-0009","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840220420","article-title":"Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture","volume":"22","author":"Muntan\u00e9-Relat","year":"1995","journal-title":"Hepatology."},{"key":"10.1002\/jcph.112-BIB0010|jcph112-cit-0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjc.6600448","article-title":"Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response","volume":"87","author":"Rivory","year":"2002","journal-title":"Br J Cancer."},{"key":"10.1002\/jcph.112-BIB0011|jcph112-cit-0011","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00228-012-1266-x","article-title":"Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients","volume":"68","author":"Naito","year":"2012","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1002\/jcph.112-BIB0012|jcph112-cit-0012","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-6576.2009.02104.x","article-title":"Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia","volume":"54","author":"Zwisler","year":"2010","journal-title":"Acta Anaesthesiol Scand."},{"key":"10.1002\/jcph.112-BIB0013|jcph112-cit-0013","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1476-5381.2010.00709.x","article-title":"Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety","volume":"160","author":"Samer","year":"2010","journal-title":"Br J Pharmacol."},{"key":"10.1002\/jcph.112-BIB0014|jcph112-cit-0014","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-5728(95)00148-4","article-title":"The influence of cytokines on the integrity of the blood-brain barrier in vitro","volume":"64","author":"de Vries","year":"1996","journal-title":"J Neuroimmunol."},{"key":"10.1002\/jcph.112-BIB0015|jcph112-cit-0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0024-3205(95)00008-T","article-title":"Systemic cytokine administration can affect blood-brain barrier permeability in the rat","volume":"56","author":"Saija","year":"1995","journal-title":"Life Sci."},{"key":"10.1002\/jcph.112-BIB0016|jcph112-cit-0016","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00000658-199802000-00015","article-title":"Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response","volume":"227","author":"Fearon","year":"1998","journal-title":"Ann Surg."},{"key":"10.1002\/jcph.112-BIB0017|jcph112-cit-0017","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/PL00012351","article-title":"Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia","volume":"23","author":"Fearon","year":"1999","journal-title":"World J Surg."},{"key":"10.1002\/jcph.112-BIB0018|jcph112-cit-0018","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S0029665108007131","article-title":"An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer","volume":"67","author":"McMillan","year":"2008","journal-title":"Proc Nutr Soc."},{"key":"10.1002\/jcph.112-BIB0019|jcph112-cit-0019","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1615\/CritRevOncog.v17.i3.80","article-title":"Multitargeted treatment of cancer cachexia","volume":"17","author":"Madeddu","year":"2012","journal-title":"Crit Rev Oncog."},{"key":"10.1002\/jcph.112-BIB0020|jcph112-cit-0020","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1177\/0091270010388033","article-title":"CYP3A5*3 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone","volume":"51","author":"Naito","year":"2011","journal-title":"J Clin Pharmacol."},{"key":"10.1002\/jcph.112-BIB0021|jcph112-cit-0021","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1213\/ane.0b013e3181605a15","article-title":"Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia","volume":"106","author":"Lemberg","year":"2008","journal-title":"Anesth Analg."},{"key":"10.1002\/jcph.112-BIB0022|jcph112-cit-0022","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00228-009-0775-8","article-title":"Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone","volume":"66","author":"Saari","year":"2010","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1002\/jcph.112-BIB0023|jcph112-cit-0023","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1526-4637.2009.00583.x","article-title":"Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options","volume":"10","author":"Porreca","year":"2009","journal-title":"Pain Med."},{"key":"10.1002\/jcph.112-BIB0024|jcph112-cit-0024","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.112-BIB0025|jcph112-cit-0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0009-9236(97)90100-4","article-title":"Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation","volume":"61","author":"Tallgren","year":"1997","journal-title":"Clin Pharmacol Ther."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.112","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.112\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:02:28Z","timestamp":1657803748000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.112"}},"subtitle":["The Journal of Clinical Pharmacology"],"short-title":[],"issued":{"date-parts":[[2013,6,3]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.112","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,3]]}}}